CompletedNCT02942199
MySafeRx & MedicaSafe Buprenorphine Induction and Lapse Evaluation (MyMOBILE)
This study is completed in the United States. It focuses on Addiction.
In CambridgeAddictionBehavioralFrom 18 Years to 39 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT02778282
MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including SomervilleAddictionBehavioralFrom 18 Years to 39 Years
CompletedNCT01797575
N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolarity
This study exists to compare options and see whether acceptance and commitment therapy, a talking treatment, offers something meaningfully different. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can better support energy, concentration, and everyday functioning.
In HoustonBipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
CompletedNCT01063348
N-Acetyl Cysteine in Pathologic Skin Picking
This summary needs review. Please check the official study record and contact the research team for details.
In ChicagoOCDDrugFrom 18 Years to 64 Years
CompletedNCT00967005
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including New HavenAddictionDrugFrom 18 Years to 75 Years
CompletedNCT01354132
N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis
This summary needs review. Please check the official study record and contact the research team for details.
In BostonSchizophreniaDrugFrom 18 Years to 35 Years
CompletedNCT01885338
N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia
This summary needs review. Please check the official study record and contact the research team for details.
In Los AngelesSchizophreniaDrugFrom 18 Years to 65 Years
CompletedNCT01172275
N-acetylcysteine (NAC) for Pediatric OCD
This summary needs review. Please check the official study record and contact the research team for details.
In New HavenOCDDrugFrom 8 Years to 17 Years
CompletedNCT00751257
N-Acetylcysteine and Smoking Reduction
This summary needs review. Please check the official study record and contact the research team for details.
In CharlestonAddictionBehavioralFrom 18 Years to 65 Years
TerminatedNCT00539513
N-Acetylcysteine Augmentation in Treatment-Refractory OCD
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedOCDDrugFrom 18 Years to 65 Years
TerminatedNCT02335060
N-acetylcysteine Effects on Tetrahydrocannabinol
This summary needs review. Please check the official study record and contact the research team for details.
In West HavenSchizophreniaDrugFrom 18 Years to 55 Years
CompletedNCT02737358
N-acetylcysteine for Addiction
This summary needs review. Please check the official study record and contact the research team for details.
In CharlestonAddictionBehavioralFrom 18 Years to 65 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.